Clinical trial
A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections…
NCT00239993 · Teva Neuroscience, Inc., Industry · Completed
Key facts
| NCT number | NCT00239993 |
|---|---|
| Title | A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone® |
| Official title | An Open-Label, Randomized, Single Cross-over Study of Warm Compress Versus Usual Injection Site Preparation on Local Injection Site Reactions Among Persons With MS Who Perform Daily Injections of Copaxone®. |
| Lead sponsor | Teva Neuroscience, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug, Procedure |
| Interventions | glatiramer acetate, Warm compress prior to injection of glatiramer acetate |
| Enrollment | 50 |
| Start date | Aug 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Oct 17, 2005 |
| Last update posted | Feb 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: